» Authors » Juan Carlos Gabaldon-Figueira

Juan Carlos Gabaldon-Figueira

Explore the profile of Juan Carlos Gabaldon-Figueira including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 14
Citations 35
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
1.
Gabaldon-Figueira J, Ros-Lucas A, Martinez-Peinado N, Blackburn G, Losada-Galvan I, Posada E, et al.
Parasit Vectors . 2024 Nov; 17(1):459. PMID: 39521974
Background: Chagas disease, caused by the parasite Trypanosoma cruzi, is a zoonosis that affects more than seven million people. Current limitations on the diagnosis of the disease hinder the prognosis...
2.
Gabaldon-Figueira J, Losada-Galvan I, Rolon M, Ardiles-Ruesjas S, Chena L, Cubilla Z, et al.
Acta Trop . 2024 Oct; 260:107408. PMID: 39424494
No abstract available.
3.
Gabaldon-Figueira J, Losada-Galvan I, Rolon M, Ardiles-Ruesjas S, Chena L, Cubilla Z, et al.
Acta Trop . 2024 Sep; 259:107382. PMID: 39244140
The diagnosis of Chagas disease mostly relies on the use of multiple serologic tests that are often unavailable in many of the remote settings where the disease is highly prevalent....
4.
Ros-Lucas A, Gabaldon-Figueira J, Martinez-Peinado N, Losada-Galvan I, Posada E, Escabia E, et al.
J Infect Dis . 2024 Aug; 230(6):1518-1528. PMID: 39194054
Chagas disease is a neglected tropical infection that affects millions of people. This study explores transcriptomic changes in Trypanosoma cruzi-infected subjects before and after treatment. Using total RNA sequencing, gene...
5.
Martinez-Peinado N, Gabaldon-Figueira J, Rodrigues Ferreira R, Carmen Thomas M, Lopez M, Cremonini Araujo-Jorge T, et al.
PLoS Negl Trop Dis . 2024 Aug; 18(8):e0012166. PMID: 39146233
Chagas disease, caused by the parasite Trypanosoma cruzi, affects over 6 million people, mainly in Latin America. Two different clinical phases, acute and chronic, are recognised. Currently, 2 anti-parasitic drugs...
6.
Gonzalez Martinez A, Losada-Galvan I, Gabaldon-Figueira J, Martinez-Peinado N, Magalhaes Saraiva R, Fernandez M, et al.
PLoS Negl Trop Dis . 2024 Aug; 18(8):e0012364. PMID: 39146231
The NHEPACHA Iberoamerican Network, founded on the initiative of a group of researchers from Latin American countries and Spain, aims to establish a research framework for Chagas disease that encompasses...
7.
Sanna A, Suarez-Mutis M, Lambert Y, Carvalho L, Cairo H, Cox H, et al.
Lancet Glob Health . 2024 Apr; 12(5):e875-e881. PMID: 38614635
The Guiana Shield, a small region of South America, is currently one of the main hotspots of malaria transmission on the continent. This Amazonian area is characterised by remarkable socioeconomic,...
8.
Sanchez-Olivieri I, Rudd M, Gabaldon-Figueira J, Carmona-Torre F, Del Pozo J, Moorsmith R, et al.
BMJ Open Respir Res . 2023 Nov; 10(1). PMID: 37945314
Introduction: Despite its high prevalence and significance, there is still no widely available method to quantify cough. In order to demonstrate agreement with the current gold standard of human annotation,...
9.
Gabaldon-Figueira J, Skjefte M, Longhi S, Escabia E, Garcia L, Ros-Lucas A, et al.
Expert Rev Anti Infect Ther . 2023 Nov; 21(12):1287-1299. PMID: 37933443
Introduction: Chagas disease, caused by parasite , is the most important neglected tropical disease in the Americas. Two drugs are available for treatment, but access to them is challenging, in...
10.
Gabaldon-Figueira J, Martinez-Peinado N, Escabia E, Ros-Lucas A, Chatelain E, Scandale I, et al.
Res Rep Trop Med . 2023 Jun; 14:1-19. PMID: 37337597
Chagas disease is the most important protozoan infection in the Americas, and constitutes a significant public health concern throughout the world. Development of new medications against its etiologic agent, ,...